LPCU.F Stock Overview
An investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the People's Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Lee's Pharmaceutical Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.20 |
| 52 Week High | HK$0.24 |
| 52 Week Low | HK$0.0001 |
| Beta | 0.92 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -81.65% |
Recent News & Updates
Recent updates
Shareholder Returns
| LPCU.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 1.5% | 1.7% |
| 1Y | n/a | 15.0% | 26.3% |
Return vs Industry: Insufficient data to determine how LPCU.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how LPCU.F performed against the US Market.
Price Volatility
| LPCU.F volatility | |
|---|---|
| LPCU.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.9% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 16.0% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: LPCU.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine LPCU.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 1,182 | n/a | www.leespharm.com |
Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the People's Republic of China. The company focuses on various disease areas, including cardiovascular, woman health, paediatrics, rare diseases, oncology, dermatology, obstetrics, and urology. It operates through Proprietary and Generic Products; and Licensed-In Products segments.
Lee's Pharmaceutical Holdings Limited Fundamentals Summary
| LPCU.F fundamental statistics | |
|---|---|
| Market cap | US$110.38m |
| Earnings (TTM) | -US$15.20m |
| Revenue (TTM) | US$172.15m |
0.6x
P/S Ratio-7.3x
P/E RatioIs LPCU.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LPCU.F income statement (TTM) | |
|---|---|
| Revenue | HK$1.35b |
| Cost of Revenue | HK$516.66m |
| Gross Profit | HK$833.29m |
| Other Expenses | HK$952.47m |
| Earnings | -HK$119.18m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.20 |
| Gross Margin | 61.73% |
| Net Profit Margin | -8.83% |
| Debt/Equity Ratio | 11.4% |
How did LPCU.F perform over the long term?
See historical performance and comparison